Edesa Biotech, Inc. (EDSA)

Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $64.51 million. The enterprise value is $52.46 million.

Market Cap	64.51M
Enterprise Value	52.46M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 8.89 million shares outstanding. The number of shares has increased by 110.15% in one year.

Current Share Class	8.89M
Shares Outstanding	8.89M
Shares Change (YoY)	+110.15%
Shares Change (QoQ)	+13.01%
Owned by Insiders (%)	7.96%
Owned by Institutions (%)	4.12%
Float	4.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	12.99
P/TBV Ratio	23.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.82

Current Ratio	16.82
Quick Ratio	16.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -96.38% and return on invested capital (ROIC) is -64.39%.

Return on Equity (ROE)	-96.38%
Return on Assets (ROA)	-55.33%
Return on Invested Capital (ROIC)	-64.39%
Return on Capital Employed (ROCE)	-59.87%
Weighted Average Cost of Capital (WACC)	0.49%
Revenue Per Employee	n/a
Profits Per Employee	-$459,761
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +211.59% in the last 52 weeks. The beta is -0.68, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	-0.68
52-Week Price Change	+211.59%
50-Day Moving Average	4.98
200-Day Moving Average	2.74
Relative Strength Index (RSI)	59.78
Average Volume (20 Days)	247,456

Short Selling Information

The latest short interest is 396,830, so 4.47% of the outstanding shares have been sold short.

Short Interest	396,830
Short Previous Month	603,458
Short % of Shares Out	4.47%
Short % of Float	9.67%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.35M
Pretax Income	-7.82M
Net Income	-7.82M
EBITDA	-8.25M
EBIT	-8.35M
Earnings Per Share (EPS)	-$1.14

Balance Sheet

The company has $12.05 million in cash and n/a in debt, with a net cash position of $12.05 million or $1.36 per share.

Cash & Cash Equivalents	12.05M
Total Debt	n/a
Net Cash	12.05M
Net Cash Per Share	$1.36
Equity (Book Value)	13.95M
Book Value Per Share	0.56
Working Capital	11.96M

Cash Flow

Operating Cash Flow	-7.89M
Capital Expenditures	n/a
Depreciation & Amortization	101,624
Net Borrowing	n/a
Free Cash Flow	-7.89M
FCF Per Share	-$0.89

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-110.15%
Shareholder Yield	-110.15%
Earnings Yield	-12.12%
FCF Yield	-12.23%

Analyst Forecast

The average price target for Edesa Biotech is $5.00, which is -31.13% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	-31.13%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1